Anna E Marneth
8PUBLICATIONS
70CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Apr 03, 2026
Sialic acid cis-ligand dynamics modulate Siglec-7 and -9 function and affect Siglec-7/9 co-blockade to potentiate natural killer cell anti-tumor activity.Jesper van Eck van der Sluijs, Anne H C Valk, Eline J H van Houtum
|Feb 26, 2026
Mutant SRSF2-associated impaired erythropoiesis is defined by increased mTORC1 signaling due to FYN missplicing.Jonas S Jutzi, Edie Crosse, Chulwoo J Kim
|Feb 24, 2026
Risk stratification of patients with TP53-mutated myeloproliferative neoplasms.Benjamin Rolles, Cilomar Martins de Oliveira Filho, Nathan Fergusson
|Sep 18, 2024
Risk of bleeding in patients with essential thrombocythemia and extreme thrombocytosis.Rathnam K Venkat, Robert A Redd, Amyah C Harris
|Dec 06, 2022
CALR-mutated cells are vulnerable to combined inhibition of the proteasome and the endoplasmic reticulum stress response.Jonas S Jutzi, Anna E Marneth, María José Jiménez-Santos
|Jun 28, 2022
Whole-genome CRISPR screening identifies N-glycosylation as a genetic and therapeutic vulnerability in CALR-mutant MPNs.Jonas S Jutzi, Anna E Marneth, Michele Ciboddo
Pageof 2
Frequent Collaborators
4 joint publications
Ann Mullally
3 joint publications
Marlise R Luskin
3 joint publications
Benjamin Rolles
3 joint publications
Jonas S Jutzi
3 joint publications
Joan How
3 joint publications
R Coleman Lindsley
3 joint publications
Lachelle D Weeks
2 joint publications
Daniel J DeAngelo
2 joint publications
Fátima Al-Shahrour
2 joint publications
Gabriela S Hobbs
